Literature DB >> 19636646

Soft-tissue sarcoma metastases identified on abdomen and pelvis CT imaging.

David M King1, Donald A Hackbarth, Chris M Kilian, Guillermo F Carrera.   

Abstract

UNLABELLED: The current standard of care for patients with extremity soft-tissue sarcomas is to obtain imaging of the chest for staging and surveillance. Our institutional standard of care has been to obtain CT scans of the chest, abdomen, and pelvis to evaluate for metastatic disease. Cost and radiation risk led us to question the utility of the additional scans. We presumed abdomen and pelvic CT scans would not benefit this patient population. We retrospectively reviewed our sarcoma databases from 2000 to 2008. We included 124 patients with 15 types of extremity soft tissue sarcomas evaluated with CT of the C/A/P. Primary outcomes were (1) location of metastatic disease in relation to (2) sarcoma type. Twenty patients (16%) presented with or developed abdomen/pelvis metastases and 10 of the 15 types of soft tissue sarcomas had abdominal or pelvic metastases. A larger number of patients demonstrated metastatic disease in the abdomen and pelvis than anticipated. We believe routine imaging of the abdomen and pelvic with CT for both staging and surveillance of all types of soft tissue sarcoma should be considered. LEVEL OF EVIDENCE: Level III, diagnostic study. See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2009        PMID: 19636646      PMCID: PMC2758993          DOI: 10.1007/s11999-009-0989-1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Radiation dose management: weighing risk versus benefit.

Authors:  J R Haaga
Journal:  AJR Am J Roentgenol       Date:  2001-08       Impact factor: 3.959

Review 2.  Effective doses in radiology and diagnostic nuclear medicine: a catalog.

Authors:  Fred A Mettler; Walter Huda; Terry T Yoshizumi; Mahadevappa Mahesh
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

3.  Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables.

Authors:  Alexander Stojadinovic; Denis H Y Leung; Peter Allen; Jonathan J Lewis; David P Jaques; Murray F Brennan
Journal:  J Clin Oncol       Date:  2002-11-01       Impact factor: 44.544

4.  Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.

Authors:  P W Pisters; D H Leung; J Woodruff; W Shi; M F Brennan
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

5.  Primary extremity sarcoma: what is the appropriate follow-up?

Authors:  B P Whooley; J F Gibbs; M M Mooney; B E McGrath; W G Kraybill
Journal:  Ann Surg Oncol       Date:  2000 Jan-Feb       Impact factor: 5.344

6.  Patterns of recurrence in patients with high-grade soft-tissue sarcomas.

Authors:  D A Potter; J Glenn; T Kinsella; E Glatstein; E E Lack; C Restrepo; D E White; C A Seipp; R Wesley; S A Rosenberg
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

7.  Frequent incidence of extrapulmonary sites of initial metastasis in patients with liposarcoma.

Authors:  E Y Cheng; D S Springfield; H J Mankin
Journal:  Cancer       Date:  1995-03-01       Impact factor: 6.860

Review 8.  Surveillance strategies for patients following surgical resection of soft tissue sarcomas.

Authors:  John M Kane
Journal:  Curr Opin Oncol       Date:  2004-07       Impact factor: 3.645

Review 9.  Soft tissue sarcomas.

Authors:  Janice N Cormier; Raphael E Pollock
Journal:  CA Cancer J Clin       Date:  2004 Mar-Apr       Impact factor: 508.702

10.  Diagnostic CT scans: assessment of patient, physician, and radiologist awareness of radiation dose and possible risks.

Authors:  Christoph I Lee; Andrew H Haims; Edward P Monico; James A Brink; Howard P Forman
Journal:  Radiology       Date:  2004-03-18       Impact factor: 11.105

View more
  12 in total

1.  Initial McGill experience with fluorodeoxyglucose pet/ct staging of soft-tissue sarcoma.

Authors:  D Roberge; M Hickeson; M Charest; R E Turcotte
Journal:  Curr Oncol       Date:  2010-11       Impact factor: 3.677

2.  What Is the Clinical Importance of Incidental Findings on Staging CT Scans in Patients With Sarcoma?

Authors:  Zachary Mayo; Sean Kennedy; Yubo Gao; Benjamin J Miller
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

3.  Accuracy and role of contrast-enhanced CT in diagnosis and surgical planning in 88 soft tissue tumours of extremities.

Authors:  Lucia Verga; Elena Maria Brach Del Prever; Alessandra Linari; Sara Robiati; Armanda De Marchi; Domenico Martorano; Michele Boffano; Raimondo Piana; Carlo Faletti
Journal:  Eur Radiol       Date:  2015-10-08       Impact factor: 5.315

Review 4.  Follow-up Strategies for Primary Extremity Soft-tissue Sarcoma in Adults: A Systematic Review of the Published Literature.

Authors:  Dietmar Dammerer; Annelies VAN Beeck; Viktoria Schneeweiss; Anton Schwabegger
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

5.  Screening and surveillance CT abdomen/pelvis for metastases in patients with soft-tissue sarcoma of the extremity.

Authors:  M J Thompson; J Ross; G Domson; W Foster
Journal:  Bone Joint Res       Date:  2015-03       Impact factor: 5.853

Review 6.  UK guidelines for the management of soft tissue sarcomas.

Authors:  Adam Dangoor; Beatrice Seddon; Craig Gerrand; Robert Grimer; Jeremy Whelan; Ian Judson
Journal:  Clin Sarcoma Res       Date:  2016-11-15

7.  Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre study.

Authors:  Maria A Smolle; Angelika Schaffler; Andreas Leithner; Veroniek M Van Praag; Marko Bergovec; Joanna Szkandera; Bernadette Liegl-Atzwanger; Maya Niethard; Per-Ulf Tunn; Michiel Van De Sande; Dimosthenis Andreou
Journal:  J Surg Oncol       Date:  2020-01-31       Impact factor: 3.454

8.  FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma.

Authors:  David Roberge; Siavosh Vakilian; Yazan Z Alabed; Robert E Turcotte; Carolyn R Freeman; Marc Hickeson
Journal:  Sarcoma       Date:  2012-12-02

9.  Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.

Authors:  Shu-Hsuan Claire Hsu; Puviindran Nadesan; Vijitha Puviindran; William B Stallcup; David G Kirsch; Benjamin A Alman
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

10.  Case Report: An incidental finding of an metastases noted in a "cancer to cancer adrenal tumor " from a large malignant nerve sheath tumor of the thigh.

Authors:  Matthew D Shaines; Shitij Arora
Journal:  F1000Res       Date:  2017-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.